title: Bilateral panocular involvement with mantle-cell lymphoma.
authors.affiliation: Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
authors.forename: Aimee V
authors.initials: AV
authors.lastname: Chappelow
authors.forename: Arun D
authors.initials: AD
authors.lastname: Singh
authors.forename: Victor L
authors.initials: VL
authors.lastname: Perez
authors.forename: Alan
authors.initials: A
authors.lastname: Lichtin
authors.forename: Brad
authors.initials: B
authors.lastname: Pohlman
authors.forename: Roger
authors.initials: R
authors.lastname: Macklis
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005134:Eye Neoplasms / Q000473:pathology* / Q000628:therapy; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D020522:Lymphoma, Mantle-Cell / Q000473:pathology* / Q000628:therapy; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D016499:Radioimmunotherapy; D011882:Radiotherapy, High-Energy; D014792:Visual Acuity
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C119496:tositumomab I-131; D011241:Prednisone